相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Thyroid dysfunctions secondary to cancer immunotherapy
P. Chalan et al.
JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION (2018)
Exacerbation of autoimmune hemolytic anemia induced by the first dose of programmed death-1 inhibitor pembrolizumab: a case report
Kenta Ogawa et al.
INVESTIGATIONAL NEW DRUGS (2018)
Safety of Programmed Death-1 Pathway Inhibitors Among Patients With Non-Small-Cell Lung Cancer and Preexisting Autoimmune Disorders
Giulia C. Leonardi et al.
JOURNAL OF CLINICAL ONCOLOGY (2018)
Myocarditis in Patients Treated With Immune Checkpoint Inhibitors
Syed S. Mahmood et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2018)
Nivolumab-induced severe pancytopenia in a patient with lung adenocarcinoma
Kentaro Tokumo et al.
LUNG CANCER (2018)
Nivolumab-induced cold agglutinin syndrome successfully treated with rituximab
Merve Hasanov et al.
BLOOD ADVANCES (2018)
Autoimmune hemolytic anemia after nivolumab treatment in Hodgkin lymphoma responsive to immunosuppressive treatment. A case report
Magalie P. Tardy et al.
HEMATOLOGICAL ONCOLOGY (2017)
Post-Babesiosis Warm Autoimmune Hemolytic Anemia
Ann E. Woolley et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Hepatotoxicity with Vismodegib: An MD Anderson Cancer Center and Research on Adverse Drug Events and Reports Project
Beatrice J. Edwards et al.
DRUGS IN R&D (2017)
Immunotherapy-associated autoimmune hemolytic anemia
Uqba Khan et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2017)
Idiopathic thrombocytopenic purpura and autoimmune neutropenia induced by prolonged use of nivolumab in Hodgkin's lymphoma
A. Bulbul et al.
ANNALS OF ONCOLOGY (2017)
Anti-PD-1-related cryoglobulinemia during treatment with nivolumab in NSCLC patient
B. Pellegrino et al.
ANNALS OF ONCOLOGY (2017)
Adverse Renal Effects of Immune Checkpoint Inhibitors: A Narrative Review
Rimda Wanchoo et al.
AMERICAN JOURNAL OF NEPHROLOGY (2017)
Immune-related adverse events with immune checkpoint blockade: a comprehensive review
J. M. Michot et al.
EUROPEAN JOURNAL OF CANCER (2016)
Autoimmune hemolytic anemia induced by anti-PD-1 therapy in metastatic melanoma
Benjamin Y. Kong et al.
MELANOMA RESEARCH (2016)
Immunotherapy-Associated Hemolytic Anemia with Pure Red-Cell Aplasia
Ranjit Nair et al.
NEW ENGLAND JOURNAL OF MEDICINE (2016)
Fulminant Myocarditis with Combination Immune Checkpoint Blockade
Douglas B. dbj Johnson et al.
NEW ENGLAND JOURNAL OF MEDICINE (2016)
Development of Hemolytic Anemia in a Nivolumab-Treated Patient with Refractory Metastatic Squamous Cell Skin Cancer and Chronic Lymphatic Leukemia
K. S. Schwab et al.
CASE REPORTS IN ONCOLOGY (2016)
Autoimmune Hemolytic Anemia as a Complication of Nivolumab Therapy
Amruth R. Palla et al.
CASE REPORTS IN ONCOLOGY (2016)
Cardiovascular and pulmonary adverse events in patients treated with BCR-ABL inhibitors: Data from the FDA Adverse Event Reporting System
Jorge Cortes et al.
AMERICAN JOURNAL OF HEMATOLOGY (2015)
The Evolving Role of Immune Checkpoint Inhibitors in Cancer Treatment
Gregory K. Pennock et al.
ONCOLOGIST (2015)
Immune evasion in cancer: Mechanistic basis and therapeutic strategies
Dass S. Vinay et al.
SEMINARS IN CANCER BIOLOGY (2015)
Characteristics and outcome of warm autoimmune hemolytic anemia in adults: new insights based on a single-center experience with 60 patients
Mathilde Roumier et al.
AMERICAN JOURNAL OF HEMATOLOGY (2014)
Immune Checkpoint Blockade
Jarushka Naidoo et al.
HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA (2014)
PD-1 blockade induces responses by inhibiting adaptive immune resistance
Paul C. Tumeh et al.
NATURE (2014)
Warm autoimmune hemolytic anemia: Advances in pathophysiology and treatment
M. Michel
PRESSE MEDICALE (2014)
Fatal Immune Hemolytic Anemia Following Allogeneic Stem Cell Transplantation: Report of 2 Cases and Review of Literature
Jordina Rovira et al.
TRANSFUSION MEDICINE REVIEWS (2013)
Severe sustained cholestatic hepatitis following temozolomide in a patient with glioblastoma multiforme: case study and review of data from the FDA adverse event reporting system
Giselle Sarganas et al.
NEURO-ONCOLOGY (2012)
Cancer Immunoediting: Integrating Immunity's Roles in Cancer Suppression and Promotion
Robert D. Schreiber et al.
SCIENCE (2011)
Warm Autoimmune Hemolytic Anemia: Recent Progress in Understanding the Immunobiology and the Treatment
Melca M. O. Barros et al.
TRANSFUSION MEDICINE REVIEWS (2010)
Autoimmune hemolytic anemia as a paraneoplastic phenomenon in solid tumors: A critical analysis of 52 cases reported in the literature
Joe Puthenparambil et al.
WIENER KLINISCHE WOCHENSCHRIFT (2010)
PD-L1 regulates the development, maintenance, and function of induced regulatory T cells
Loise M. Francisco et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2009)
Drug-induced immune hemolytic anemia
G. Garratty
Hematology-American Society of Hematology Education Program (2009)
分享论文
